|4Feb 10, 2:58 PM ET

Bailey Megan D. 4

4 · LABCORP HOLDINGS INC. · Filed Feb 10, 2026

Research Summary

AI-generated summary of this filing

Updated

Labcorp EVP Megan Bailey Exercises RSUs; Shares Withheld

What Happened

  • Megan D. Bailey, EVP and President, Central Labs & International at Labcorp Holdings (LH), had restricted stock units (RSUs) vest and converted into common stock on Feb 6–7, 2026. A total of 469 RSUs were settled into shares (180 on Feb 6; 222 and 67 on Feb 7). To satisfy tax withholding obligations, 180 shares were withheld (72 on Feb 6; 85 and 23 on Feb 9) for a total tax-withholding value of $49,551. Net shares received after withholding: 289.

Key Details

  • Transaction dates and amounts:
    • 2026-02-06: 180 RSUs converted to 180 shares; 72 shares withheld at $277.20 = $19,958 (tax withholding).
    • 2026-02-07: 222 and 67 RSUs converted to 289 shares total.
    • 2026-02-09: 85 shares withheld at $274.01 = $23,291 and 23 shares withheld at $274.01 = $6,302 (tax withholding).
  • Total RSUs converted: 469. Total shares withheld for taxes: 180. Net shares delivered to insider: 289.
  • Total cash value withheld for taxes: $49,551.
  • Footnotes: F1 = each RSU converts to one share; F2 = stock withholding used to satisfy tax obligations; F3/F5 note the applicable vesting schedules for the grants; F4 references aggregate RSUs held (number not shown in this extract).
  • Filing: Report filed 2026-02-10 covering transactions dated 2026-02-06 to 2026-02-09 — appears timely (no late filing noted).

Context

  • These were RSU settlements (derivative conversion), not open-market sales or purchases. The withholding of shares to cover taxes is routine (a cashless/stock-withholding settlement) and does not necessarily signal a buy or sell decision by the insider.
  • For retail investors: RSU vesting is a common form of compensation; such filings are primarily administrative (vesting + tax withholding) unless accompanied by open-market trades.

Insider Transaction Report

Form 4
Period: 2026-02-06
Bailey Megan D.
EVP, Pres, Central Labs & Intl
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-06+1803,774 total
  • Tax Payment

    Common Stock

    [F2]
    2026-02-06$277.20/sh72$19,9583,702 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-07+2223,924 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-07+673,991 total
  • Tax Payment

    Common Stock

    [F2]
    2026-02-09$274.01/sh85$23,2913,906 total
  • Tax Payment

    Common Stock

    [F2]
    2026-02-09$274.01/sh23$6,3023,883 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F1][F3][F4]
    2026-02-061802,419 total
    Common Stock (180 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F1][F5][F4]
    2026-02-072222,197 total
    Common Stock (222 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F1][F5][F4]
    2026-02-07672,130 total
    Common Stock (67 underlying)
Footnotes (5)
  • [F1]Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
  • [F2]Stock withholding to satisfy tax withholding obligations.
  • [F3]The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.
  • [F4]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
  • [F5]The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested.
Signature
/s/ Kathryn W. Kyle, Attorney-in-Fact for Megan D. Bailey|2026-02-10

Documents

2 files
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY